International Deprescribing Guidelines Did Not Impact Actual Practice in Deprescribing of Potentially Inappropriate Medications for Nursing Home Residents: An Interrupted Time Series Analysis

Veehof L, Stewart R, Haaijer-Ruskamp F, et al. The development of polypharmacy. A longitudinal study. Fam Pract. 2000;17(3):261–7. https://doi.org/10.1093/fampra/17.3.261.

Article  CAS  PubMed  Google Scholar 

Morin L, Laroche ML, Texier G, et al. Prevalence of Potentially inappropriate medication use in older adults living in nursing homes: a systematic review. J Am Med Dir Assoc. 2016;17(9):862.e1-9. https://doi.org/10.1016/j.jamda.2016.06.011.

Article  PubMed  Google Scholar 

Tamura BK, Bell CL, Inaba M, et al. Outcomes of polypharmacy in nursing home residents. Clin Geriatr Med. 2012;28(2):217–36. https://doi.org/10.1016/j.cger.2012.01.005.

Article  PubMed  Google Scholar 

Lion S, Evrard P, Foulon V, et al. Drug–drug interactions in nursing home residents: analysis from the COME-ON trial. Age Ageing. 2023. https://doi.org/10.1093/ageing/afac278.

Article  PubMed  Google Scholar 

Storms H, Marquet K, Aertgeerts B, et al. Prevalence of inappropriate medication use in residential long-term care facilities for the elderly: a systematic review. Eur J Gen Pract. 2017;23(1):69–77. https://doi.org/10.1080/13814788.2017.1288211.

Article  PubMed  PubMed Central  Google Scholar 

Anrys PMS, Strauven GC, Foulon V, et al. Potentially inappropriate prescribing in Belgian nursing homes: prevalence and associated factors. J Am Med Dir Assoc. 2018;19(10):884–90. https://doi.org/10.1016/j.jamda.2018.06.010.

Article  PubMed  Google Scholar 

Wallace E, McDowell R, Bennett K, et al. Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: a prospective cohort study. J Gerontol Ser A. 2016;72(2):271–7. https://doi.org/10.1093/gerona/glw140.

Article  Google Scholar 

Ruggiero C, Dell’Aquila G, Gasperini B, et al. Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging. 2010;27(9):747–58. https://doi.org/10.2165/11538240-000000000-00000.

Article  PubMed  Google Scholar 

Dalleur O, Spinewine A, Henrard S, et al. Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging. 2012;29(10):829–37. https://doi.org/10.1007/s40266-012-0016-1.

Article  PubMed  Google Scholar 

Guillot J, Justice AC, Gordon KS, et al. Contribution of potentially inappropriate medications to polypharmacy-associated risk of mortality in middle-aged patients: a national cohort study. J Gen Intern Med. 2024. https://doi.org/10.1007/s11606-024-08817-4.

Article  PubMed  Google Scholar 

Alshammari H, Al-Saeed E, Ahmed Z, et al. Reviewing potentially inappropriate medication in hospitalized patients over 65 using explicit criteria: a systematic literature review. Drug Healthc Patient Saf. 2021;13:183–210. https://doi.org/10.2147/DHPS.S303101.

Article  PubMed  PubMed Central  Google Scholar 

Hurley E, Dalton K, Byrne S, et al. Pharmacist-led deprescribing using STOPPFrail for frail older adults in nursing homes. J Am Med Dir Assoc. 2024;25(9): 105122. https://doi.org/10.1016/j.jamda.2024.105122.

Article  PubMed  Google Scholar 

Roh E, Cota E, Lee JP, et al. Polypharmacy in nursing homes. Clin Geriatr Med. 2022;38(4):653–66. https://doi.org/10.1016/j.cger.2022.05.007.

Article  PubMed  Google Scholar 

Statbel en het Federaal Planbureau. Bevolkingsvooruitzichten 2023–2070 [updated February 13, 2024; cited 2024 April 08]. https://www.plan.be/databases/data-35-nl-bevolkingsvooruitzichten_2022_2070. Accessed Jan 2023.

Gerkens S, Lefèvre M, Bouckaert N, et al. Performance of the Belgian health system: Report 2024. Health Services Research (HSR). Brussels. Belgian Health Care Knowledge Centre (KCE). 2024. KCE Reports 376C. https://doi.org/10.57598/R376C.

Anlay DZ, Paque K, Van Leeuwen E, et al. Tools and guidelines to assess the appropriateness of medication and aid deprescribing: an umbrella review. Br J Clin Pharmacol. 2024;90(1):12–106. https://doi.org/10.1111/bcp.15906.

Article  PubMed  Google Scholar 

Nyborg G, Straand J, Klovning A, et al. The Norwegian general practice—nursing home criteria (NORGEP-NH) for potentially inappropriate medication use: a web-based Delphi study. Scand J Prim Health Care. 2015;33(2):134–41. https://doi.org/10.3109/02813432.2015.1041833.

Article  PubMed  PubMed Central  Google Scholar 

Khodyakov D, Ochoa A, Olivieri-Mui BL, et al. Screening tool of older person’s prescriptions/screening tools to alert doctors to right treatment medication criteria modified for US nursing home setting. J Am Geriatr Soc. 2017;65(3):586–91. https://doi.org/10.1111/jgs.14689.

Article  PubMed  Google Scholar 

Dijk MMT, Catharina AM, Pouw CK, Hertogh CMPM, et al. Medication appropriateness for older nursing home patients with a limited life expectancy: from STOPP/START version 2 to the ReNeWAL criteria. J Am Med Dir Assoc. 2024. https://doi.org/10.1016/j.jamda.2024.105143.

Article  PubMed  Google Scholar 

Lavan AH, Gallagher P, Parsons C, et al. STOPPFrail (Screening tool of older persons prescriptions in frail adults with limited life expectancy): consensus validation. Age Ageing. 2017;46(4):600–7. https://doi.org/10.1093/ageing/afx005.

Article  PubMed  Google Scholar 

Morin L, Laroche ML, Vetrano DL, et al. Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus. Eur J Clin Pharmacol. 2018;74(10):1333–42. https://doi.org/10.1007/s00228-018-2507-4.

Article  PubMed  PubMed Central  Google Scholar 

Curtin D, Gallagher P, O’Mahony D. Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2. Age Ageing. 2021;50(2):465–71. https://doi.org/10.1093/ageing/afaa159.

Article  PubMed  Google Scholar 

Bjerre LM, Farrell B, Hogel M, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline. Can Fam Physician Medecin de Famille Canadien. 2018;64(1):17–27.

PubMed  Google Scholar 

Tordoff JM, Ailabouni NJ, Browne DP, et al. Improvements in the prescribing of antipsychotics in dementia and psychogeriatric units in New Zealand. Int J Clin Pharm. 2016;38(4):941–9. https://doi.org/10.1007/s11096-016-0318-1.

Article  CAS  PubMed  Google Scholar 

Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Physician. 2017;63(5):354–64.

PubMed  PubMed Central  Google Scholar 

Curtin D, Jennings E, Daunt R, et al. Deprescribing in older people approaching end of life: a randomized controlled trial using STOPPFrail criteria. J Am Geriatr Soc. 2020;68(4):762–9. https://doi.org/10.1111/jgs.16278.

Article  PubMed  Google Scholar 

Evrard P, Damiaens A, Patey AM, et al. Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: a qualitative study of stakeholder groups. Explor Res Clin Soc Pharm. 2023;9: 100258.

PubMed  PubMed Central  Google Scholar 

Farrell B, Conklin J, Dolovich L, et al. Deprescribing guidelines: an international symposium on development, implementation, research and health professional education. Res Soc Adm Pharm. 2019;15(6):780–9. https://doi.org/10.1016/j.sapharm.2018.08.010.

Article  Google Scholar 

Langford AV, Warriach I, McEvoy AM, et al. What do clinical practice guidelines say about deprescribing? A scoping review. BMJ Qual Saf. 2024. https://doi.org/10.1136/bmjqs-2024-017101.

Article  PubMed  PubMed Central  Google Scholar 

Benchimol EI, Smeeth L, Guttmann A, et al. The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12(10): e1001885. https://doi.org/10.1371/journal.pmed.1001885.

Article  PubMed  PubMed Central  Google Scholar 

Maetens A, De Schreye R, Faes K, et al. Using linked administrative and disease-specific databases to study end-of-life care on a population level. BMC Palliat Care. 2016;15:1–10. https://doi.org/10.1186/s12904-016-0159-7.

Article  Google Scholar 

Norwegian Institute of Public Health. ATC/DDD Index. https://atcddd.fhi.no/atc_ddd_index/. Accessed 6 Aug 2024.

Paque K, De Schreye R, Elseviers M, et al. Discontinuation of medications at the end of life: a population study in Belgium, based on linked administrative databases. Br J Clin Pharmacol. 2019;85(4):827–37. https://doi.org/10.1111/bcp.13874.

Article  PubMed  PubMed Central  Google Scholar 

Deprescribing guidelines and algorithms. [cited 2022/06/12].

Comments (0)

No login
gif